Core discharge mechanisms and technology maturity

Plasma ozone generation produces ozone (O₃) via electrically driven gas discharges — the core reaction pathway being O₂ + e⁻ → O + O + e⁻, followed by O + O₂ + M → O₃ + M — a well-established route documented across the patent and literature records in this dataset. The technology spans dielectric barrier discharge (DBD), corona discharge, surface micro-discharge, and atmospheric-pressure plasma jets (APPJs), with DBD representing the dominant architecture across all active filings reviewed.

The innovation timeline in this dataset spans from the 1890s through to early 2026. Foundational patents — from Welsbach Corporation (FR, 1958), Union Carbide Corp. (FR, 1976–1977), and Olin Mathieson Chemical Corporation (FR, 1957) — established silent electric discharge ozonizers, corona gap optimisation, and oxygen-rich feed gas. These are entirely inactive and represent closed art. The 1931 Bamag-Meguin patent described spiral electrode geometries still echoed in contemporary coaxial-spiral designs.

A development era spanning 2000–2018 saw Korean microwave plasma apparatus filings, module-type plasma ozone generation systems from Eco Set Co., Ltd. (Ecoset Corporation, KR, 2015), and industrial-scale system integration from Toshiba Mitsubishi-Electric Industrial Systems Corporation (TMEIC) in EP (2018). The current innovation cluster — 2019 to 2026 — is where active IP density is highest, characterised by smart delivery control, plasma vortex architecture, and AI-integrated water treatment.

Dominant DBD architectures and efficiency benchmarks

Dielectric barrier discharge is the dominant plasma ozone generation architecture, found in tube-type, plate-type, coaxial-spiral, and surface configurations across the majority of active filings in this dataset. A dielectric material — typically glass or ceramic — separates high-voltage electrodes, generating a non-thermal plasma in the discharge gap. Key performance parameters include gap length (sub-80 µm in high-density designs), operating frequency (typically 1–10 kHz), applied voltage (2.5–12 kV), and feed gas composition (pure oxygen versus atmospheric air).

Beyond the standard tube-type DBD, several distinct sub-architectures are active in the current filing landscape. TMEIC’s 2021 JP patent describes a discharge cell with gap length below 80 µm for high-concentration output. ORK Co., Ltd.’s 2023 Korean filing introduces a 24-cell plate-module design with integrated cooling, remote monitoring, and compact form factor — a design philosophy oriented toward modular scalability rather than single-cell optimisation.

A distinct cold plasma sub-cluster from Acvalens Ltd. (Acvalens, IL) describes parallel-plate flat electrode geometry with a perimeter-hole in-electrode paired with a centre-hole out-electrode to distribute gas flow uniformly across the discharge gap, addressing reliability limitations of conventional corona generators. Acvalens holds at least four active IL patents on this architecture, representing a concentrated single-assignee cluster.

“A coaxial-spiral DBD achieves 67 g/kWh at 1 Nl/min, rising to 93 g/kWh at 100 Nl/min — a key efficiency benchmark for evaluating competing plasma ozone generation architectures.”

UV-photocatalytic and LED-photocatalytic generation represents a non-discharge pathway of growing interest. TMEIC’s 2020 EP patent describes nitrogen-free ozone generation using photocatalytic material applied to the discharge surface. A separate 2022 JP filing describes LED-photocatalyst cell pairs generating ozone for engine ignition assist. Oak Manufacturing Co., Ltd. (Oak Seisakusho) filed a 2024 JP patent on excimer lamp-based generation with precision on/off cycling specifically designed to prevent UV efficiency degradation over time — a practical durability concern absent from earlier UV ozone literature. According to WIPO, photocatalytic ozone generation represents one of the fastest-growing sub-categories within environmental technology patent filings.

Application domains: water treatment to automotive emissions

Water treatment and purification is the most heavily represented application domain in this dataset, spanning municipal water disinfection, peat water remediation, and industrial wastewater treatment. The fusion of plasma generation with ozone microbubble injection represents the current frontier — two January 2026 Korean pending filings from EE Company Co., Ltd. (EE Company Corporation) describe full AI-controlled systems integrating microbial activity measurements, inflow and effluent sensor data, and algorithmic logic to dynamically regulate a combined plasma generator and ozone ultrafine bubble injector.

Indoor air sterilisation and deodorisation represent a growing consumer and industrial electronics sub-domain. Japanese filings from Maxell Ltd. and NGK Spark Plug Co., Ltd. (Niterra Co., Ltd.) dominate here. NGK’s 2021 JP filing describes dual inside/outside ozone concentration control for food storage containers; its 2022 filing extends this to battery-optimised ozone supply for long-duration food preservation in off-grid containers — a practical adaptation for cold-chain logistics in energy-constrained environments.

In medical and pharmaceutical contexts, double DBD (DDBD) reactor designs from Diponegoro University specify ozone dose parameters suitable for therapeutic applications. NorthStar Medical Radioisotopes LLC’s 2024 EP filing describes a closed-loop spectrophotometric control system for medical equipment sterilisation via ozonated water — an approach that integrates real-time ozone concentration measurement directly into the sterilisation feedback loop. Standards bodies including ISO maintain active technical committees on ozone measurement and safety for medical device sterilisation.

Automotive emissions control represents a technically distinct niche. Denso Corporation’s 2021 JP patent describes an ozone generation system in which voltage, frequency, and flow velocity are controlled dynamically based on NOx sensor feedback — adding ozone to exhaust streams to convert NO to NO₂ and improve low-temperature lean NOx trap (LNT) catalyst adsorption efficiency. Innovation Green Technology S.r.l. filed a 2018 IT patent on a spiral wire micro-discharge generator for internal combustion engine integration.

Geographic and assignee patent landscape

Japan holds the highest concentration of active, substantive plasma ozone generation patents in this dataset, with at least 10 active filings. The dominant Japanese assignees are Toshiba Mitsubishi-Electric Industrial Systems Corporation (TMEIC), Mitsubishi Electric Corporation, NGK Spark Plug Co., Ltd. (Niterra Co., Ltd.), Maxell Ltd., Denso Corporation, and Oak Manufacturing Co., Ltd. (Oak Seisakusho). Japan leads in system integration, smart delivery, and industrial-scale designs.

Korea is the second most active jurisdiction with at least 8 active or pending filings, covering plasma vortex architecture, modular DBD systems, plasma-ozone microbubble fusion, and individual-inventor plasma discharge generators (Jung Woo-Nam). Korean filings span the full range from basic discharge devices to AI-integrated water treatment systems, with notable contributions from Korean SMEs and individual inventors alongside larger entities.

In Europe, TMEIC and Mitsubishi Electric hold active EP filings. Italian assignees — Multiossigen S.p.A., Innovation Green Technology S.r.l., and Plume S.r.l. — contribute niche active filings. Israel’s Acvalens Ltd. holds a concentrated single-assignee cluster of four active IL patents. US active filings in this dataset are predominantly design patents, with limited substantive utility patent representation — a pattern that IP strategists should treat with caution, as it may reflect PCT filing strategy (PCT → US national phase) rather than absence of protected technology.

The innovation landscape is moderately concentrated at the high-end industrial scale — TMEIC and Mitsubishi Electric — but increasingly distributed at the mid-scale, with active contributions from Korean SMEs, Israeli startups, and Italian niche players. According to EPO trend data, environmental technology patent filings have grown consistently across Asian jurisdictions over the past decade, consistent with the Japan and Korea dominance observed here.

Emerging directions: AI control, plasma vortex, and low-ozone plasma

Five distinct forward trajectories are identifiable from the 2023–2026 filings in this dataset, each representing a substantively different innovation vector rather than incremental improvement to existing DBD cell designs.

1. AI and intelligent automation-controlled plasma-ozone microbubble fusion (2026)

Two January 2026 Korean pending filings from EE Company Co., Ltd. (EE Company Corporation) describe systems where an intelligent automation (IA) control means integrates microbial activity measurements — specifically oxygen uptake rate (OUR) — alongside inflow and effluent sensor data and algorithmic logic to dynamically start, stop, and regulate a combined plasma generator and ozone ultrafine bubble injector. This marks a shift from fixed-parameter discharge control toward closed-loop bioprocess-responsive operation, a combination with no strong prior art cluster in the dataset.

2. IoT-integrated occupancy-responsive ozone delivery (2024–2025)

Maxell Ltd.’s 2024 and 2025 JP filings describe ozone generators that receive control information from third-party communication devices — occupancy sensors, congestion data — to adjust ozone emission without adding dedicated sensors to the generator itself. This low-cost IoT integration approach positions ozone generators as nodes in smart building management systems, a design philosophy that separates sensing from generation hardware.

3. Low-ozone atmospheric plasma for biomedical applications (2023)

Plume S.r.l.’s EP patent (2023) describes a surface DBD (SDBD) method operated intermittently to generate atmospheric plasma while keeping ozone output below 0.5 ppmv — and preferably below the 0.2 ppmv regulatory threshold. This inverts the conventional objective of maximising ozone yield. Occupational exposure limits cited in the retrieved literature are 60–100 ppb; Plume’s approach directly addresses that barrier, enabling direct human-proximate biomedical or surface treatment applications that would otherwise require ozone destruction systems.

“Rather than maximising ozone yield, Plume S.r.l.’s SDBD method keeps ozone output below 0.2 ppmv — a non-obvious inversion of conventional plasma ozone generator design goals that opens a distinct biomedical application category.”

4. Non-invasive plasma diagnostics for real-time process control (2025)

Dublin City University’s 2025 JP patent describes a Radio Emission Spectroscopy (RES)-based system using an external antenna to measure near-field E-field and B-field signals from plasma chambers through viewports, enabling real-time non-invasive characterisation of plasma state. While primarily aimed at semiconductor plasma processes, this diagnostic methodology is directly applicable to ozone generation process control — and represents a potential enabler for the closed-loop AI control systems described in the 2026 Korean filings.

5. Plasma vortex architecture for efficiency gains (2025)

Eco Insight Co., Ltd.’s (Eco Insight Corporation) March 2025 Korean patent introduces a magnetic body-augmented vortex discharge tube that creates helical flow patterns within concentric DBD electrode-dielectric assemblies. The magnetic body surrounds the outer ground electrode, converting gas flow into a vortex pattern that maximises contact time between activated species and feed gas, with first-path discharge enclosed in two concentric flow paths. The filing claims higher ozone output per unit energy compared to conventional tube-type generators.

Strategic implications for IP and R&D teams

DBD remains the core platform technology for plasma ozone generation, but differentiation is moving upstream and downstream of the discharge cell. Power electronics optimisation — multi-unit parallel reactors with variable-inductance tuning, as in Mitsubishi Electric’s JP 2022 filing — smart delivery control (Maxell, NGK), and downstream application integration (TMEIC’s multi-treatment-apparatus supply systems) are where recent IP density is highest. Entering the field with a pure DBD cell design faces a dense prior art landscape; the strategic question is which adjacent layer to target.

The plasma-ozone microbubble fusion combined with AI control represents an open white space in the current dataset. The two 2026 EE Company filings are pending, and the integration of OUR-based microbial sensing with plasma control is novel. R&D teams focused on advanced wastewater treatment should monitor this cluster closely and consider adjacent IP positions in dissolved ozone sensing and feedback control algorithms.

Japan and Korea are the dominant active-patent jurisdictions; US representation in substantive utility patents is limited in this dataset. IP strategists targeting the US market should conduct targeted freedom-to-operate analysis, as the apparent gap may reflect PCT filing strategy — PCT to US national phase — rather than absence of protected technology. Korean SME activity is high and growing, particularly in modular and smart systems.

Solar-powered microplasma and point-of-use ozone generation remain underserved by the patent literature relative to their documented efficacy. Research published through institutions tracked by NIH and environmental engineering journals has documented the efficacy of low-power microplasma ozone for water disinfection, but the University of Illinois at Chicago’s 2020 study demonstrating 15-watt solar-sufficient microplasma ozone for point-of-use water disinfection — achieving a 2.3-log E. coli reduction — has no corresponding strong patent cluster in this dataset. This represents a potential white-space opportunity for humanitarian and off-grid applications. PatSnap’s R&D intelligence platform provides tools for mapping exactly these kinds of research-to-patent gaps.

The low-ozone plasma direction (sub-0.2 ppmv, Plume S.r.l., EP, 2023) has significant freedom-to-operate implications for plasma medicine and cosmetics. Regulatory compliance with occupational exposure limits — 60–100 ppb per retrieved literature — is a commercialisation barrier for many indoor plasma applications; Plume’s intermittent SDBD operation method directly addresses that barrier and opens a distinct application category not served by conventional ozone generator designs. Teams at PatSnap for IP management can help identify FTO risks in this emerging sub-domain.